You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 261 No. 23, June 16, 1989 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Anti-HIV Substances for Rape Victims

Ilene M. Foster
Baltimore County Health Department Towson, Md

John Bartlett, MD
The Johns Hopkins University School of Medicine Baltimore, Md

JAMA. 1989;261(23):3407.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

In the age of human immunodeficiency virus (HIV) infection, physicians responsible for the initial treatment of victims of sexual assault would do well to reevaluate and update treatment procedures for female victims of rape.

Historically, victims of sexual assault have been specifically instructed not to wash or douche prior to examination by a physician. Such examinations routinely include a history, examination for injuries, collection of evidence, and counseling. With concern for the possible transmission of HIV, those caring for rape victims should consider topical treatment with nonoxynol 9, 1:10 vinegar solution, or similar anti-HIV substances (B. Voeller, personal communication, September 1988).1,2

Much as been written in recent years of the efficacy of nonoxynol 9 in inactivation of sexually transmitted disease pathogens including HIV.1-3 We submit that a treatment revision for victims of sexual assault should include the early administration of nonoxynol 9 as a potential . . . [Full Text PDF of this Article]


Footnotes

Edited by Drummond Rennie, MD, Deputy Editor (West).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.